Chaves, Yane Costa; Genaro, Karina; Crippa, José Alexandre de Souza 
; Cunha, Joice Maria da; Zanoveli, Janaina Menezes
Source: Metabolic Brain Disease. Unidade: FMRP
Subjects: ANSIOLÍTICOS, ANTIDEPRESSIVOS, CANABINOIDES, DIABETES MELLITUS, FARMACOTERAPIA, SEROTONINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAVES, Yane Costa et al. Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action. Metabolic Brain Disease, v. 36, n. 4, p. 639-652, 2021Tradução . . Disponível em: https://doi.org/10.1007/s11011-020-00667-3. Acesso em: 13 nov. 2024.APA
Chaves, Y. C., Genaro, K., Crippa, J. A. de S., Cunha, J. M. da, & Zanoveli, J. M. (2021). Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action. Metabolic Brain Disease, 36( 4), 639-652. doi:10.1007/s11011-020-00667-3NLM
Chaves YC, Genaro K, Crippa JA de S, Cunha JM da, Zanoveli JM. Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action [Internet]. Metabolic Brain Disease. 2021 ; 36( 4): 639-652.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s11011-020-00667-3Vancouver
Chaves YC, Genaro K, Crippa JA de S, Cunha JM da, Zanoveli JM. Cannabidiol induces antidepressant and anxiolytic‐like effects in experimental type-1 diabetic animals by multiple sites of action [Internet]. Metabolic Brain Disease. 2021 ; 36( 4): 639-652.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s11011-020-00667-3
